Vijaya Diagnostic Centre Ltd

Vijaya Diagnostic Centre Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure will be effective from Thursday, October 1, 2026, until 48 hours after the public announcement of the company's unaudited financial results for the quarter ending September 30, 2026. The exact date of the board meeting to declare these results will be communicated later. All designated persons and their relatives are advised against trading in the company's securities during this period, in compliance with SEBI regulations and the company's code of conduct.

Vijaya Diagnostic Centre Ltd has executed a Business Transfer Agreement (BTA) to acquire 100% of Arya Wellness Centre, a B2C-focused integrated diagnostic center in Guwahati, Assam, for approximately ₹46 crore. This acquisition marks Vijaya's entry into the North-East India diagnostics market and strengthens its presence in Eastern India. Arya Wellness Centre, established in 2021, offers comprehensive radiology and pathology services. In FY26, it recorded revenue of ₹26 crore, with IND AS EBITDA of ₹5.6 crore and IND AS Adjusted PAT of ₹2.5 crore. The transaction, valued at approximately 8-9x FY26 IND AS EBITDA, is expected to close within three months and be EPS accretive from the outset. This strategic move aligns with Vijaya's growth strategy for geographic expansion and B2C focus.

Vijaya Diagnostic Centre Ltd announced its Board of Directors has approved the acquisition of the integrated diagnostic business undertaking of Arya Wellness Centre from NEMRIL HRPL JV for a cash consideration of ₹46.20 Crores. The acquisition, structured as a slump sale, is expected to be completed within 90 days and is part of the company's strategy to expand its diagnostic business into Assam and strengthen its presence in North-East India. The target business had a turnover of ₹26.95 Crores in FY 2025-26. This transaction does not involve related parties.

Vijaya Diagnostic Centre Ltd has announced the appointment of Dr. Venkata Naresh Yallapragada as its new Chief Information Officer (CIO), effective September 02, 2026. Dr. Yallapragada brings over 23 years of experience in Healthcare IT, with a background combining clinical practice and technology strategy. He has previously held senior IT leadership roles at prominent hospital groups, including KIMS Hospitals, Rainbow Children's Medicare, and Maxivision Eye Hospitals, where he led significant digital transformation initiatives. His expertise spans HIS/EMR implementations, cybersecurity, AI-driven systems, and enterprise analytics. Dr. Yallapragada is also a recognized thought leader in the healthcare informatics space.

Ms. Naga Vasudha Tadepalli has resigned as Company Secretary & Compliance Officer of Vijaya Diagnostic Centre Ltd due to personal reasons. Her last day of employment will be August 26, 2026. The company has provided detailed disclosures as per SEBI regulations, including the reason for change and the cessation date. Ms. Tadepalli expressed gratitude for her tenure and committed to a smooth handover.

Vijaya Diagnostic Centre Ltd has announced its 24th Annual General Meeting (AGM) will be held on Thursday, September 24, 2026, at 11:00 AM IST via Video Conferencing (VC)/Other Audio Visual Means (OAVM). In compliance with SEBI regulations, the company is sending web links to shareholders whose email addresses are not registered, providing the exact navigation path to access the Annual Report for FY 2025-26. Shareholders are encouraged to register or update their email addresses to receive future communications electronically.

Vijaya Diagnostic Centre Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, as required by SEBI regulations. The report, which is part of the Annual Report, details the company's corporate identity, business activities, operations, and employee data. The company operates on a standalone basis and provides comprehensive diagnostic services across pathology and radiology. It serves a diverse customer base including individuals, hospitals, and corporate clients, primarily within India, with no export contribution to turnover. The report also includes data on employee demographics, including a small number of differently-abled employees and a significant representation of women in leadership roles.

Vijaya Diagnostic Centre Ltd has announced the record date for its final dividend and e-voting for the upcoming Annual General Meeting (AGM). The company's Board of Directors recommended a final dividend of ₹2 per equity share for FY 2025-26, subject to shareholder approval. The record date for determining entitlement to this dividend and for e-voting eligibility has been fixed as Wednesday, September 16, 2026. The AGM is scheduled for Thursday, September 24, 2026, to be held via Video Conferencing. E-voting will commence on September 21, 2026, and conclude on September 23, 2026. The dividend, if approved, will be paid within 30 days of the AGM.

Vijaya Diagnostic Centre Ltd has announced its 24th Annual General Meeting (AGM) will be held on September 24, 2026, at 11:00 AM IST via Video Conferencing/Other Audio-Visual Means. The agenda includes adopting the audited standalone and consolidated financial statements for FY26, declaring a final dividend of ₹2 per equity share, re-appointing a director, ratifying the Cost Auditor's remuneration at ₹50,000 plus taxes, and approving amendments to the VDCL Employee Stock Option Plan, 2018, to increase the stock option pool by 20,00,000 options.

Vijaya Diagnostic Centre Ltd has filed its Annual Report for the financial year 2025-26. The report includes the Notice of the 24th Annual General Meeting (AGM), scheduled for September 24, 2026, to be held via Video Conferencing. The Annual Report, along with the Business Responsibility and Sustainability Report, has been disseminated to shareholders via email and uploaded to the company's website. The report details the company's corporate overview, statutory reports, financial statements, and discusses its performance, infrastructure, journey, presence, strategy, and digital innovation.